Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.23
Delayed Data
As of May 22
 -0.0049 / -2.09%
Today’s Change
0.21
Today|||52-Week Range
0.40
-8.00%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.23
Today’s open0.23
Day’s range0.22 - 0.24
Volume2,094,793
Average volume (3 months)1,812,235
Market cap$53.5M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+31.33%
P/E ratioNM
Price/Sales238.95
Price/Book1.88

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...+0.06+2.41%
ADMPAdamis Pharmaceutica...+0.05+1.25%
ENZNEnzon Pharmaceutical...0.000.00%
HTBXHeat Biologics Inc+0.12+1.90%
Data as of 4:00pm ET, 05/22/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$197.0K
Annual profit (last year)-$17.5M
Net profit margin-8,857.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, Chief Executive Officer &
CSO
William A. Carter
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers